Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 436

Document Document Title
WO/2000/071118A1
The invention concerns novel phospholipase A¿2? specific inhibiting compounds of general formula (I). Said novel compounds are capable of acting on PLA¿2? and are advantageously PLA¿2?snp-specific inhibiting compounds completely inact...  
WO/2000/069862A2
Methods are provided for preparing a compound with a fused ring structure of formula (XIV) which comprises one or more reactions starting from a 21-cyano compound of formula (XVI) where typically: R?1¿ is an amidomethylene group or an a...  
WO/2000/063195A1
The current invention discloses novel heterocyclic amino carbonyl derivatives useful as nitric oxide synthase inhibitors  
WO/2000/042029A1
1-Heterocycle substituted diarylamines, methods of making and using them, and compositions containing them.  
WO/2000/039109A1
The invention relates to a method for producing 6-methyl-3,4-dihydro-1,2,3-oxathiazin-4-one-2,2-dioxide by reacting 5-chloro-6-methyl-3,4 dihydro-1,2,3-oxathiazin-4-one-2,2 dioxide with hydrogen in the presence of a base and a catalyst, ...  
WO/2000/031036A1
Novel naphthalene derivatives represented by general formula (1), which exhibit an excellent fibrinolysis accelerating effect and are useful as orally administrable antithrombotic or thrombolytic agents.  
WO/2000/027795A1
Disclosed are compounds capable of facilitating transport of biologically active agents or substances into cells having general structure (A).  
WO/2000/012084A1
The present invention relates to novel geometrically restricted 2-indolinones and physiologically acceptable salts thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treat...  
WO/2000/010969A1
Novel sulfonylimide and sulfonylmethide compounds are described which are useful as conductive salts. Also described is the use of the above compounds in salt form in battery electrolytes, particular salts having mixed perfluorocarbon an...  
WO1999058500B1
The invention relates to a method for stereochemically controlled production of azacyclic compounds of general formula (I), whereby the substituents have the meaning cited in the description. The invention also relates to intermediate pr...  
WO/1999/057116A2
The invention relates to novel methoximinomethyloxathiazines of formula (I), to two methods for producing them and to their use as pesticides.  
WO/1999/031074A2
Novel amines of formulas (1A) and (1B) or a pharmaceutically acceptable salt thereof wherein: n is an integer of from 0 to 2; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic acid, or hydroxamic acid; A is hydrogen or meth...  
WO/1999/031075A1
Novel amines of formulas (1), (1C), (1F), (1G) and (1H) or a pharmaceutical acceptable salt thereof wherein n is an integer of from 0 to 2; m is an integer of from 0 to 3; R is sulfonamide, amide, phosphonic acid, heterocycle, sulfonic a...  
WO/1999/025701A1
The invention relates to carboxylic acid derivatives of formula (I) wherein A represents NR?8¿R?9¿, azido, OR?10¿, SR?10¿ or C¿1?-C¿4? alkyl, R?1¿ represents tetrazole or a group (1), wherein R has the following meaning: a) a radi...  
WO/1999/005131A1
Compounds of formula (I) are useful as nitric oxide synthase inhibitors.  
WO/1998/051665A2
This invention relates to macrocyclic molecules of formula (I) which inhibit metalloproteinases, including aggrecanase, and the production of tumor necrosis factor (TNF). The present invention also relates to pharmaceutical compositions ...  
WO/1998/039006A1
The present invention is directed toward the use of the drug Troglitazone and related thiazolidinedione compounds in the treatment of the climacteric and cancer. This use is based on the novel discovery that Troglitazone inhibits steroid...  
WO/1998/034929A1
The invention relates to certain 8-ureido and 8-thioureido 1,2-benzothiazines, 1,2,4-benzothioxazines and 1,2,4-benzothiodiazines useful in the treatment of disease states mediated by the chemokine, Interleukin-8.  
WO/1998/031682A1
The invention concerns 4-(3-heterocyclyl-1-benzoyl)pyrazoles of formula (I) in which the variables have the following meanings: R?1�, R?3�: hydrogen, nitro, halogen, cyano, alkyl, alkyl halide, alkoxy, alkoxy halide, alkylthio, alkyl...  
WO/1998/031681A1
The invention concerns benzoyl derivatives of formula (I) in which the variables have the following meanings: R?1�, R?2�: hydrogen, nitro, halogen, cyano, alkyl, alkyl halide, alkoxy, alkoxy halide, alkylthio, alkylthio halide, alkyl...  
WO/1998/025598A2
Methods for inhibiting proliferation of a PPAR$g(g)-responsive hyperproliferative cell using PPAR$g(g) agonists are described. Pharmaceutical compositions as well as methods for diagnosing and treating a PPAR$g(g)-responsive hyperprolife...  
WO/1998/023601A1
A process for the preparation of a compound having the structure of Formula (I) wherein A, R�1?, R�2?, R�3?, Y and Z are as defined in the disclosure. The process includes reacting a heterocyclic amine with a monoaldehyde or a dial...  
WO/1998/017653A1
The invention relates to novel oxime derivatives of formula (I) , in which A stands for alkadiyl, Ar for optionally substituted aryls or heteroaryls respectively, G for a single bond, optionally an alkandiyl interrupted by heteroatoms (i...  
WO/1998/009955A1
This invention provides intermediates and processes useful for the preparation of crytophycin compounds.  
WO/1998/008505A1
The invention provides novel cryptophycin compounds which can be useful for disrupting the microtubulin system, as anti-neoplastic agents, and for the treatment of cancer. The invention further provides a formulation for administering th...  
WO/1997/042185A1
Compounds of formula (I), and their N-oxides and agriculturally suitable salts, are disclosed which are useful for controlling undesired vegetation. In said formula (I) Q is (Q-1), (Q-2) or (Q-3); and A, R1-R7, and q are as defined in th...  
WO/1997/041199A1
Novel bleaches, a method for bleaching substrates using these materials and detergent compositions containing same are reported. The bleaches are sulfanimines. Substrates such as fabrics may be bleached in an aqueous solution containing ...  
WO/1997/030038A1
Compounds represented by the following general formula: A-C(X)(Y)-C(R1)(R2)-Z wherein Z represents, for example, -N(R3)-(CH2)p-B [wherein R3 represents alkyl, etc.; p is an integer of from 3 to 8; and B represents a group represented by ...  
WO/1997/018207A2
This invention relates to macrocyclic molecules which inhibit metalloproteinases, including aggrecanase, and the production of tumor necrosis factor (TNF). In particular, the compounds are inhibitors of metalloproteinases involved in tis...  
WO/1996/033984A1
Novel N-sulfoxy anhydrides, a process for the preparation thereof and its use for the preparation of bioactive substances having ACE inhibitory action. Novel compounds of formula (III), wherein R1 represents PhCH2-CH2- or CH3CH2-CH2- and...  
WO/1996/025406A1
Compounds of formula (I) in which A is possibly substituted alkylene, Ar is possibly substituted arylene or heteroarylene, E is preferably one of the grouping (a), (b), (c), (d), (e), Y1 is oxygen, sulphur or a possibly alkyl-substituted...  
WO/1996/017835A1
The invention pertains to novel oxathiazolinones of formula (I), a method for preparing them and their use as fungicides.  
WO/1996/016950A1
A HIV-1 protease inhibitor which includes an N-terminal cycle (A) or a C-terminal cycle (B) or both cycles (A) and (B) wherein Y is selected from side chains of Asn or Ile or Val or Glu and alkyl of 1-6 carbon atoms inclusive of linear o...  
WO/1995/025104A1
A compound of the formula (I), or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof, wherein, X represents a moiety of formula (a), in which A1 represents -CH=CH=, NH, S or O; A2 represents an o...  
WO/1995/022082A1
The invention relates to a colour-photographic recording material which comprises a magenta coupler and, as stabilizer, at least one compound of formula (Ia), (Ib) or (II), where the radicals are as defined in claim 1, and to the novel s...  
WO/1995/007697A2
Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations at risk for developing noninsulin-dependent diabetes mellitus (NIDDM) and complications arising therefrom are disclosed. In one e...  
WO/1995/007694A1
Novel methods of using thiazolidinone derivatives and related antihyperglycemic agents to treat populations experiencing impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus (NIDDM) ...  
WO/1995/005739A1
Use of 3-aryl-5,6-dihydro-1,4,2-oxathiazines and their oxides having formula (I), wherein n is 0, 1 or 2; R1 is hydrogen, C1-4alkyl or benzyl; and R represents (a) phenyl; phenyl substituted with 1 to 3 substituents independently selecte...  
WO/1995/006043A1
The present invention provides certain 3-aryl-5,6-dihydro-1,4,2-oxathiazines and their oxides, useful for the long-term preservation of wood and composite wood materials against wood damaging and wood destroying materials. The present in...  
WO/1995/001979A1
The present invention relates to novel heterocyclic compounds having general formula (1) wherein: X is O, S, Se, or NR2; Y1, Y2, Y3, Y4 independently are N or CR2; Z is O, S, Se, NR2 or C = N; and A is (a) or (b) wherein W is O, S, NH or...  
WO/1994/002483A1
The present invention relates to heterocyclic compounds of formula (I), which have been found to have anti-tumour activity. More specifically, the invention concerns Pyrrolo [3,2-b_] carbazoles, 1H-Benzofuro [3,2-f_] indoles and 1H-[1] B...  
WO/1993/019055A1
According to a process for preparing acesulfam salts by reacting amidosulfonic acid salts with diketen, yielding an acetoacetamidosulfonic acid salt (I), ring closure is effected under the influence of an at least equivalent amount of SO...  
WO/1993/004071A1
Benzothiazolone derivatives of formula (I), wherein Y is oxygen or sulfur; R¿1? is hydrogen or fluorine; and R¿2? is hydrogen, C¿1?-C¿6?alkyl, C¿2?-C¿4?alkenyl, or C¿2?-C¿6?alkynyl; halo-substituted C¿1?-C¿6?alkyl, C¿2?-C¿4?a...  
WO/1993/004142A1
Decomposable complex ligands may be stabilized by derivating them with blocking secondary or tertiary carbonic or sulfonic acids. Orientation layers and liquid crystal mixtures may be added to these stabilized derivates that cause in FLC...  
WO/1992/020669A1
The present invention relates to highly diastereoselective processes for production of cis-nucleosides and nucleoside analogues and derivatives in high optical purity and intermediates useful in those processes.  
WO/1992/020696A1
The present invention relates to highly diastereoselective processes for production of cis-nucleosides and nucleoside analogues and derivatives in high optical purity and intermediates useful in those processes.  
WO/1992/020662A1
Novel substituted triazolinone, triazolinethione, and triazolinimine compounds of formula (I) are useful as angiotensin II antagonists.  
WO/1992/018490A1
Bicyclic derivatives of general formula (I), wherein X1 is -S- or -SO-; X2 is -CO- or -CS-; R1 is hydrogen, halogen or lower alkyl optionally substituted by halogen or lower alkoxy; R2 and R3 are each independently hydrogen, lower alkyl,...  
WO/1992/005164A1
Aminobenzosultam derivatives as inhibitors of lipoxygenase and useful in the treatment or alleviation of allergic and inflammatory diseases.  
WO/1992/000967A1
A novel bisheterocyclic compound represented by general formula (I), which is useful as a hypoglycemic drug, and a novel hypoglycemic drug containing the same, wherein R?1¿ and R?2¿ are the same or different from each other and each re...  

Matches 151 - 200 out of 436